Eric Eugene Esser - 04 Aug 2022 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role
Chief Operating Officer
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Issuer symbol
TBIO
Transactions as of
04 Aug 2022
Net transactions value
$0
Form type
4
Filing time
08 Aug 2022, 16:03:03 UTC
Previous filing
17 Jun 2022
Next filing
05 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 04 Aug 2022 Common Stock 50,000 $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on August 4, 2024.